Elevated uric acid increases the risk for kidney disease RP Obermayr, C Temml, G Gutjahr, M Knechtelsdorfer, R Oberbauer, ... Journal of the American Society of Nephrology 19 (12), 2407-2413, 2008 | 858 | 2008 |
Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial FP Schena, MD Pascoe, J Alberu, M del Carmen Rial, R Oberbauer, ... Transplantation 87 (2), 233-242, 2009 | 685 | 2009 |
Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation JM Campistol, J Eris, R Oberbauer, P Friend, B Hutchison, JM Morales, ... Journal of the American Society of Nephrology 17 (2), 581-589, 2006 | 603 | 2006 |
Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure1, 2, 10 RWG Johnson, H Kreis, R Oberbauer, C Brattstrom, K Claesson, J Eris Transplantation 72 (5), 777-786, 2001 | 563 | 2001 |
KDIGO clinical practice guideline on the evaluation and management of candidates for kidney transplantation SJ Chadban, C Ahn, DA Axelrod, BJ Foster, BL Kasiske, V Kher, D Kumar, ... Transplantation 104 (4S1), S11-S103, 2020 | 437 | 2020 |
Mitochondrial regulation of apoptosis B Mayer, R Oberbauer Physiology 18 (3), 89-94, 2003 | 356 | 2003 |
Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation G Heinze, C Mitterbauer, H Regele, R Kramar, WC Winkelmayer, ... Journal of the American Society of Nephrology 17 (3), 889-899, 2006 | 322 | 2006 |
Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal H Kreis, R Oberbauer, JM Campistol, T Mathew, P Daloze, FP Schena, ... Journal of the American Society of Nephrology 15 (3), 809-817, 2004 | 306 | 2004 |
Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation R Oberbauer, G Segoloni, JM Campistol, H Kreis, A Mota, J Lawen, ... Transplantation 78 (2), 30, 2004 | 282 | 2004 |
Reducing the costs of chronic kidney disease while delivering quality health care: a call to action R Vanholder, L Annemans, E Brown, R Gansevoort, JJ Gout-Zwart, ... Nature Reviews Nephrology 13 (7), 393-409, 2017 | 276 | 2017 |
A randomized trial of bortezomib in late antibody-mediated kidney transplant rejection F Eskandary, H Regele, L Baumann, G Bond, N Kozakowski, ... Journal of the American Society of Nephrology 29 (2), 591-605, 2018 | 257 | 2018 |
Everolimus with reduced calcineurin inhibitor exposure in renal transplantation J Pascual, SP Berger, O Witzke, H Tedesco, S Mulgaonkar, Y Qazi, ... Journal of the American Society of Nephrology 29 (7), 1979-1991, 2018 | 254 | 2018 |
Cost-effectiveness analysis of renal replacement therapy in Austria M Haller, G Gutjahr, R Kramar, F Harnoncourt, R Oberbauer Nephrology Dialysis Transplantation 26 (9), 2988-2995, 2011 | 248 | 2011 |
Health-related quality of life outcomes after kidney transplantation W Fiebiger, C Mitterbauer, R Oberbauer Health and quality of life outcomes 2, 1-6, 2004 | 239 | 2004 |
Predictors of new-onset decline in kidney function in a general middle-european population RP Obermayr, C Temml, M Knechtelsdorfer, G Gutjahr, J Kletzmayr, ... Nephrology Dialysis Transplantation 23 (4), 1265-1273, 2008 | 227 | 2008 |
Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the rapamune maintenance regimen … R Oberbauer, H Kreis, RWG Johnson, A Mota, K Claesson, JC Ruiz, ... Transplantation 76 (2), 364-370, 2003 | 218 | 2003 |
Effect of anticoagulation on blood membrane interactions during hemodialysis R Hofbauer, D Moser, M Frass, R Oberbauer, AD Kaye, O Wagner, ... Kidney international 56 (4), 1578-1583, 1999 | 202 | 1999 |
Apoptosis of tubular epithelial cells in donor kidney biopsies predicts early renal allograft function R Oberbauer, M Rohrmoser, H Regele, F MÜHLBACHER, G Mayer Journal of the American Society of Nephrology 10 (9), 2006-2013, 1999 | 176 | 1999 |
Strategies for long-term preservation of kidney graft function T Wekerle, D Segev, R Lechler, R Oberbauer The Lancet 389 (10084), 2152-2162, 2017 | 171 | 2017 |
Zoledronic acid to prevent bone loss in the first 6 months after renal transplantation M Haas, Z Leko-Mohr, P Roschger, J Kletzmayr, C Schwarz, ... Kidney international 63 (3), 1130-1136, 2003 | 163 | 2003 |